OptiBiotix Health PLC Result of AGM
08 August 2024 - 9:29PM
RNS Regulatory News
RNS Number : 7693Z
OptiBiotix Health PLC
08 August 2024
8
August 2024
OptiBiotix Health
plc
("OptiBiotix" or the
"Company" or the "Group")
Result of
AGM
OptiBiotix Health plc (AIM: OPTI), a
life sciences business developing compounds to tackle obesity, high
cholesterol, diabetes and skin care announces that at the AGM held earlier today, all
resolutions were duly passed.
The full voting results will be
available on the website in due course here:
https://www.optibiotix-ir.com/content/investors/
For
further information, please contact:
|
OptiBiotix Health plc
|
www.optibiotix.com
|
|
Neil Davidson, Chairman
|
Contact via Walbrook
below
|
|
Stephen O'Hara, Chief
Executive
|
|
|
|
|
|
Cairn Financial Advisers LLP (NOMAD)
|
Tel: 020
7213 0880
|
|
Liam Murray / Jo Turner / Ludovico
Lazzaretti
|
|
|
Peterhouse Capital Limited (Broker)
|
Tel: 020
7220 9797
|
|
Duncan Vasey / Lucy
Williams
|
|
|
|
|
|
Walbrook PR Ltd
|
Mob: 07876
741 001
|
|
Anna Dunphy
|
|
|
|
| |
About OptiBiotix - www.optibiotix.com
OptiBiotix Health plc (AIM: OPTI),
which was formed in March 2012, brings science to the development
of compounds which modify the human microbiome - the collective
genome of the microbes in the body - in order to prevent and manage
human disease and promote wellness.
OptiBiotix has an extensive R&D
programme working with leading academics in the development of
microbial strains, compounds, and formulations which are used as
active ingredients and supplements. More than twenty international
food and healthcare supplement companies have signed agreements
with OptiBiotix to incorporate their human microbiome modulators
into a wide range of food products and drinks.
OptiBiotix is also developing its
own range of consumer supplements and health products. The
Company's current areas of focus include obesity, cardiovascular
health, and diabetes.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
RAGPPMBTMTTMBPI
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Optibiotix Health (LSE:OPTI)
Historical Stock Chart
From Dec 2023 to Dec 2024
